Feature News
05 Jun 2023
GenesisCare Unlocks US$200 Million in New Financing to Continue Strong Australia Growth Trajectory
SYDNEY—June 5, 2023--GenesisCare (or the “Company”), a leading integrated cancer care provider, announced that as part of its restructuring process, it has received access to new funding to operate its business through a financing facility provided by its largest lenders, including funds managed by Oaktree Capital Management, L.P., (“Oaktree”), Bain Capital, LP, Avenue Capital Group, Canyon Partners and Challenger Investment Management.
GenesisCare’s access to this previously announced financing, along with other approvals, will allow the company to continue its operations in the ordinary course during the restructuring process, including paying wages and benefits to doctors and employees, providing patient care as usual and making all payments to vendors in Australia. Vendors and suppliers can also expect prompt payments going forward, consistent with established payment terms.
“The new financing to which GenesisCare has gained access represents a significant vote of confidence in our business and an investment in the people who run it, including here in Australia,” said David Young, Chief Executive Officer of GenesisCare. “I was pleased to hear comments of parties in the restructuring process emphasise the importance of our doctors and our broader team to both the success of our company and the patients we serve, and, in turn, the importance of our efforts to maintain employee wages and benefits during this process.”
GenesisCare’s prospects in Australia are strong, with the Company playing a critical role in the nation’s healthcare system. Today, GenesisCare treats 40 per cent of the nation’s radiotherapy patients, equating to over 30,000 patients annually.
Said Richard Lizzio, Executive Manager, Oncology Australia, “GenesisCare is a critical piece of Australia’s healthcare system, currently treating over 1,900 patients daily across our 41 sites We are treating a record number of patients in Australia, and we see even more pent-up demand going forward. To meet this demand, we opened two new centres during May, in Albany, WA and Bella Vista, NSW, and we have two additional centres nearing completion and slated to open within a few months. Construction has either commenced or about to commence on three additional centres.”
Byron Beath, Managing Director at Oaktree, one of the largest lenders to the Company, said: “GenesisCare provides world class cancer care delivered by best-in-class doctors making it the pre-eminent cancer treatment provider for Australian communities. It provides over 40 per cent of all radiation therapy cancer treatments nationally. To support the highest levels of continued patient care and deliver new investments in patient access, GenesisCare’s largest lenders, provided it with a US$200 million (A$312 million) capital injection into the business. We are confident in the underlying business and the world class care provided by GenesisCare’s doctors. Oaktree and its investment partners look forward to working alongside the company to support continuity of patient care, long-term doctor alignment, and a right-sizing of its balance sheet.”
About GenesisCare
One of the world's largest integrated oncology networks, GenesisCare includes 300+ locations in the US, the UK, Australia and Spain. With investments in advanced technology and expanded access to clinical trials, more than 5,500 highly trained GenesisCare physicians and support staff offer comprehensive, coordinated care in radiation oncology, medical oncology, haematology, urology, diagnostics, and surgical oncology. For more information, visit genesiscare.com
Media
Scott McFarlane
Scott.mcfarlane@teneo.com
+61 2 9063 5106
Latest News
June 2023
May 2023
01 May 2023
Statement from GenesisCare
April 2023
March 2023
February 2023
January 2023
November 2022
25 Nov 2022
Celebrating our 2022 Game Changers
September 2022
August 2022
July 2022
June 2022
May 2022
13 May 2022
Radiation Oncology
WA Country Health Service and GenesisCare partner to deliver new radiation oncology facility in Albany
09 May 2022
Radiation Therapy
Radiation therapy…for sore feet? New hope for thousands of Australians living with silent foot condition
March 2022
February 2022
04 Feb 2022
Treatment and services
GenesisCare Albury Wodonga welcomes third highly advanced treatment machine
January 2022
28 Jan 2022
Medical Oncology
GenesisCare Appoints Seven Leading Oncologists to Chair its Global Research Committees
26 Jan 2022
Radiation Oncology, Breast Cancer
Leading Queensland cancer specialist recognised in Australia Day honours
19 Jan 2022
Advancing patient outcomes through research
December 2021
November 2021
29 Nov 2021
Annual research report 2020
October 2021
19 Oct 2021
Breast Cancer
Leading Hunter New England doctors urge women not to delay life-saving breast cancer screenings
19 Oct 2021
Treatment and services
Highly advanced treatment machine arrives at new integrated cancer centre in Maitland
14 Oct 2021
Celebrating our GenesisCare Game Changers
September 2021
28 Sep 2021
Prostate Cancer
Prostate cancer patients from across Peel Region benefit from new specialist nurse
August 2021
27 Aug 2021
Breast Cancer
Breast Cancer Breakthrough: GenesisCare Launches West Australian-First Breast Cancer Biomarker Test
July 2021
June 2021
25 Jun 2021
Brain and Spine Cancer
Local brain cancer patients set to benefit from new specialist brain cancer service on their doorstep
February 2021
January 2021
December 2020
10 Dec 2020
Radiation Oncology
GenesisCare’s Shepparton radiation oncology centre celebrates 1st birthday
November 2020
11 Nov 2020
Chemotherapy
Local cancer patients in Mandurah set to benefit from new chemotherapy service
October 2020
07 Oct 2020
Prostate Cancer
South Eastern Sydney welcomes world-class cancer treatment this Prostate Cancer Awareness Month
September 2020
August 2020
14 Aug 2020
Radiation Therapy
Gold Coast first: New treatment technology eliminates need for cancer patients to receive permanent clinical tattoos
July 2020
22 Jul 2020
Medical Oncology
NSW-first: Sydney man with prostate cancer first in state to receive innovative oncology treatment
June 2020
03 Jun 2020
Prostate Cancer